CIK 0000318306
- Non-accelerated filer
- Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 830221517
- Phone
- +1 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Grant or award Director acquired 38,590 shares (grant or award)
- 4 Grant or award Director acquired 77,181 shares (grant or award)
- 4 Grant or award Director acquired 38,590 shares (grant or award)
- 4 Grant or award Director acquired 77,181 shares (grant or award)
- 4 Grant or award Director acquired 38,590 shares (grant or award)
- 4 Grant or award Director acquired 77,181 shares (grant or award)
- 4 Open-market sale Director sold 80,000 shares at $2.01 ($160,888)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Accounting Officer sold 55,445 shares at an average $1.82 ($100,712)
- 4 Open-market sale Chief Executive Officer sold 45,409 shares at $1.87 ($84,919)
- 4 Grant or award Chief Executive Officer acquired 250,000 shares (grant or award)
- 4 Open-market sale Director sold 80,000 shares at $2.23 ($178,624)
- 4 Grant or award Chief Operating Officer acquired 200,000 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 50,000 shares (grant or award)
- 4 Open-market sale Director sold 45,566 shares at $2.38 ($108,502)
- 4 Open-market sale Director sold 251,625 shares at $2.39 ($601,057)
- 4 Open-market sale Director sold 132,664 shares at $2.34 ($310,168)
Page 11 of 20 · 394 filings